Dr. med. Matthias Oechsner is a specialist in neurology. After his studies, he completed his further training at the Max Planck Institute for Psychiatry in Munich and at University Medical Center Hamburg-Eppendorf (UKE). He then went on to work as a senior physician in the Department of Neurology at the University of Giessen (D) and spent eight years working as a senior consultant and Medical Director of a Parkinson’s clinic in Germany. He has been Medical Director of the Parkinson’s Center at Rehaklinik Zihlschlacht (TG) since 2011 and has also offered special Parkinson’s consultations at NeuroCentre Bellevue since 2013. For over 20 years, his clinical and research work has focused on neurological movement disorders and Parkinsonism, working specifically with special forms of treatment, such as deep brain stimulation and treatment with drug pumps.
- Since 2011
- Head of Parkinson’s Center, Rehaklinik Zihlschlacht (TG/CH)
- 2002- 2010
- Head physician and Medical Director, Parkinsonklinik Bad Nauheim (D)
- 2001- 2002
- Senior physician, Department of Neurology, University of Giessen
- Since 1995
- Clinical focus on Parkinson’s and movement disorders
- 1993- 2001
- Department of Neurology, University Hospital Eppendorf, Hamburg
- 1989- 1992
- Max Planck Institute of Psychiatry, Munich
Education and degrees
- DGN certification for botulinum toxin therapy
- Specialized neurological intensive care
- Neurology specialist
- Dissertation on transcranial electrical stimulation of the motor cortex
- Studies in medicine at Ludwig Maximilian University of Munich
- German Parkinson’s Association
- Swiss Neuological Society
- Swiss Society for Neurological Rehabilitation
Publications and lectures
- Reuter I, Mehnert S, Leone P, Kaps M, Oechsner M, Engelhardt M. Effects of a flexibility and relaxation programme, walking and nordic walking on Parkinson´s disease. Aging Res. 2011;2011:232473. Epub 2011 Mar 30.
- Morgen K, Sammer G, Weber L, Aslan B, Müller C, Bachmann GF, Sandmann D, Oechsner M, Vaitl D, Kaps M, Reuter I. Structural Brain Abnormalities in Patients with Parkinson Disease: A Comparative Voxel-Based Analysis Using T1-Weighted MR Imaging and Magnetization Transfer Imaging. AJNR Am J Neuroradiol. 2011 Dec;32(11):2080-6. Epub 2011 Nov 11.
- Reuter I, Mehnert S, Sammer G, Oechsner M, Engelhardt M. Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson’s disease. J Aging Res. 2012;2012:235765. Epub 2012 Sep 12.
- Besong-Agbo D, Wolf E, Jessen F, Oechsner M, Hametner E, Poewe W, Reindl M, Oertel WH, Noelker C, Bacher M, Dodel R. Naturally occurring a-synuclein autoantibody levels are lower in patients with Parkinson disease. Neurology 80 (2013) 169-75.
- “Oechsner M. Neurorehabilitation bei fortgeschrittenem Parkinsonsyndrom”. Schweiz Med Forum 13 (2013) 179-182.
- Oechsner M. Neuro-Reha Teil 1: Morbus Parkinson. “Aktivierende Verfahren, komplexe Therapien und hoher Zeitaufwand.” DNP / Der Neurologe und Psychiater 14 (2013) 63-66.